Category Archives: Stem Cell Research

25-Medical BiotechnologySG Part Ib. Stem Cells-Therapy and Medical Research.mov Stem cell research has created national, if not global controversy. Why? What divides our thinking about stem cell research? This section provides the basics on stem cell research including: embryonic stem cells; adult stem cells; and, induced pluri-potent stem cells. Also discussed are their potential therapeutic application for degenerative diseases.From:Albert KauschViews:0 0ratingsTime:37:33More inEducation Follow this link: 25-Medical BiotechnologySG Part Ib. Stem Cells-Therapy and Medical Research.mov - Video … Continue reading →

Art Bell CLASSIC SHOW Consciousness The Universe 03-26-2010 Art Bell CLASSIC SHOW Consciousness The Universe 03-26-2010 WATCH THE LATEST VIDEO THAT CAME OUT TODAY HERE http://www.youtube.com http://www.jetstreamnews.com If You Use Twitter heres the Twitter address or just click the twitter link on the right of the channel page twitter.com Consciousness the Universe Date: 03-26-10 Host: Art Bell Guests: Robert Lanza Filling in for George Noory, Art Bell welcomed renegade thinker and scientist, Robert Lanza, who discussed how life and consciousness are essential to the existence of our universe -- a controversial theory called "biocentrism". Numerous experiments show that everything we see out there, every single particle, depends on the presence of an observer, he said. Citing the two-hole experiment, in which particles are beamed toward a barrier with double slits, Lanza pointed out that an observed particle acts as one would expect and goes through a single hole. When unobserved, however, the particle behaves like a wave and passes through multiple slits at the same time. Lanza suggested that our observations effect the world around us as well, and without conscious observers (in the form of biological life) there would be no universe at all. Space and time are not … Continue reading →

26-Medical BiotechnologySG Part Ic. Animal and Human Cloning and Genetic Engineering.mov Some of the same techniques described for stem cell research, have been extended and applied to animal cloning, creating part of the controversies surrounding both topics. What is cloning? Cloning an organism (as a totally different process distinguished from cloning a gene) is a process whereby all members are directly descended, asexually, from a single organism by......various ways, as we show in this section, and this demonstrates that all the information required for an organism and its development are in the a single cell. many animals have now been cloned, including, sheep (Dolly), cattle, pigs, mice, rats, fish, dogs, cats, horses, mules, and more recently monkeys. Can humans be cloned? Probably.From:Albert KauschViews:0 0ratingsTime:25:57More inEducation Originally posted here: 26-Medical BiotechnologySG Part Ic. Animal and Human Cloning and Genetic Engineering.mov - Video … Continue reading →

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that chairman and CEO Gary Rabin will present at the 2012 Stem Cell Meeting on the Mesas Investor and Partnering Forum, Oct. 29 and 30 in La Jolla, California. In his presentation, Mr. Rabin will provide an overview of ACTs ocular programs. The presentation will be webcast by theAlliance for Regenerative Medicinein the weeks following the conference. The following are specific details regarding ACTs presentation at the conference: About the Stem Cell Meeting on the Mesas Investor and Partnering Forum The Investor and Partnering Forum is being organized by the Sanford Consortium, CIRM and The Alliance for Regenerative Medicine (ARM) to facilitate translational research, promote engagement between the scientific and business communities and provide opportunities for business, academic research and investor participants to connect in one-on-one strategic partnering meetings. To learn more or to register for the 2011 Stem Cell Meeting on the Mesa Symposium and Investor & Partnering Forum, please visit http://www.stemcellmeetingonthemesa.com. About Advanced Cell Technology, Inc. Advanced Cell Technology, Inc., is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com. … Continue reading →

ScienceDaily (Oct. 26, 2012) The ability of embryonic stem cells to differentiate into different types of cells with different functions is regulated and maintained by a complex series of chemical interactions, which are not well understood. Learning more about this process could prove useful for stem cell-based therapies down the road. New research from a team led by Carnegie's Yixian Zheng zeroes in on the process by which stem cells maintain their proper undifferentiated state. Their results are published in Cell October 26. Embryonic stem cells go through a process called self-renewal, wherein they undergo multiple cycles of division while not differentiating into any other type of cells. This process is dependent on three protein networks, which guide both self-renewal and eventual differentiation. But the integration of these three networks has remained a mystery. Using a combination of genetic, protein-oriented and physiological approaches involving mouse embryonic stem cells, the team -- which also included current and former Carnegie scientists Junling Jia, Xiaobin Zheng, Junqi Zhang, Anying Zhang, and Hao Jiang -- uncovered a mechanism that integrates all three networks involved in embryonic stem cell self-renewal and provide a critical missing link to understanding this process. The key is a protein … Continue reading →

CARLSBAD, CA--(Marketwire - Oct 25, 2012) - International Stem Cell Corporation ( OTCQB : ISCO ) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company focused on therapeutic and research products, today announced that its subsidiary, Lifeline Cell Technology (LCT), will begin selling products through Fisher Scientific, Inc.'s ("Fisher Scientific") online catalogue as an Encompass Preferred Supplier. Typically large pharmaceutical companies buy research supplies and products using preferred supplier agreements.Fisher Scientific is the world's largest such supplier to the life science industry with over 350,000 customers and $12 billion in annual sales. Their third party e-catalog sales have grown from $26 million in 2006 to $424 million in 2011 and represent a promising new sales channel for Lifeline Cell Technology's cell and media products. Dr. Simon Craw, ISCO's Executive Vice President of Business Development, explained, "This is a tremendous opportunity and a testament to the high quality of Life Cell Technology's products.By working with Fisher Scientific, LCT will be able to reach many more customers that we would otherwise not be able to reach.One of the biggest challenges we faced was the ability to sell into pharmaceutical companies that have preferred supplier agreements.Our inclusion in the Fisher e-catalogs and Encompass … Continue reading →

Bangkok (The Nation/ANN) - Thailand is fascinated with "roadmaps", but when it comes to life-or-death matters like regenerative science, the country has none. Shinya Yamanaka and John Gurdon cheered regenerative scientists around the world, including those working on stem-cell body rebuilding in private and public hospitals here, when they were awarded the Nobel Prize for Physiology or Medicine on October 8. But looking back at the environment at home, Thai scientists sighed. Local development of the technique has been direction-less and under-funded. Stem-cell research has drawn attention from scientists around the world, including Thai scientists, ever since South Korea's Dr Hwang Woo-suk and his team reported that they had successfully created human embryonic stem cells by cloning in 2005. Even though much of this "breakthrough" research was later found to have been faked, many researchers and scientists in Thailand continued to follow their curiosity to discover how to effectively use stem cells for treatment. Over the past decade, stem cell-related research centres have mushroomed at public and private educational institutions and hospitals across the country, such as centres for heart disease, diabetes, Alzheimer's disease, Parkinson's disease, thalassemia and leukaemia. Already this year, at least three universities have reported success in … Continue reading →

Introduction We are in the midst of a major national debate on stem cell research. There are a variety of ethical and religious views on this issue, and these perspectives are important. But there are also practical and scientific issues. The Heritage Foundation recently hosted a panel discussion to raise and discuss these issues. This paper presents excerpts from the remarks of three speakers at that event. All three have expertise in the subject and regularly address the public policy questions involved in stem cell research. Kelly Hollowell, Ph.D., is a molecular and cellular pharmacologist and a patent attorney. Phil Coelho is CEO and Chairman of the Board of Thermogenesis Corp., which provides cord blood stem cell processing and cryopreservation systems used by major cord blood stem cell banks. And Representative Dave Weldon is a physician and represents the 15th Congressional District of Florida. --Robert Moffit, Ph.D. Kelly Hollowell, Ph.D.: Embryonic stem cells are the unspecialized cells that form the basic building blocks for all of the specialized cell types in the body. Researchers hope to treat human diseases by using stem cells taken from embryos. The primary sources for embryonic stem cells are aborted fetuses and the donated and … Continue reading →

October 17, 2012 Michael Harper for redOrbit.com Your Universe Online Stem cell research, as promising as it may be, has always run into some controversial matters of ethics. As such, research into these stem cells and their relatively untapped potential could be hampered by these legal and political roadblocks. Now new research has discovered a method of harvesting pockets of cells from the scalps and brain linings of recently deceased humans then repurposing them as stem cells. With this new method, stem cells could only be a trip to the morgue away. Armed with these stem cells, scientists could develop new cell therapies as well as gain a better understanding of developmental disorders such as autism, bipolar disorder and schizophrenia. The trouble now, according to Ronald D.G. McKay of the National Institute of Neurological Disorders and Stroke, is knowing which stem cells come from embryos and which come from adult, mature human cells. Speaking with ABC News, McKay explained that there are big differences between the stem cells and so far scientists dont know enough about the two to accurately distinguish them. Fred H. Gage of the Salk Institute in LaJolla, California, who led the research, agrees. We cant look … Continue reading →

Public release date: 15-Oct-2012 [ | E-mail | Share ] Contact: Shaun Mason smason@mednet.ucla.edu 310-206-2805 University of California - Los Angeles Researchers led by Tanya Stoyanova and Dr. Owen Witte of UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have determined how a protein known as Trop2 drives the growth of tumor cells in prostate and other epithelial cancers. This discovery is important because it may prove essential for creating new therapies that stop the growth of cancer, the researchers said. The study is featured on the cover of the Oct. 15 issue of the journal Genes and Development. The Trop2 protein is expressed on the surface of many types of epithelial cancer cells cells that form tumors that grow in the skin and the inner and outer linings of organs but little was known about the protein's role in the growth and proliferation of cancer cells. The UCLA researchers discovered that Trop2 controls those processes through a mechanism that leads to the protein being cleaved into two parts, one inside the cell and one outside. This Trop2 division promotes self-renewal of the cancer cells, resulting in tumor growth. "Determining the mechanism of this protein … Continue reading →